Safety Assessment of Centella asiatica-derived Ingredients as Used

Safety Assessment of

Centella asiatica-derived Ingredients as Used in Cosmetics

Status: Final Report

Release Date: July 10, 2015

Panel Date: June15-16, 2015

The 2015 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V.

Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald

C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A.

This report was prepared by Wilbur Johnson, Jr., M.S., Senior Scientific Analyst.

1620 L STREET, NW, SUITE 1200 ◊ WASHINGTON, DC 20036-4702 ◊ PH 202.331.0651 ◊ FAX 202.331.0088 ◊ CIRINFO@CIR-SAFETY.ORG

Abstract: The Cosmetic Ingredient Review (CIR) Expert Panel (Panel) reviewed the safety of 9 Centella asiatica-derived

ingredients, which function primarily as skin conditioning agents in cosmetic products. The Panel reviewed relevant data

relating to the safety of these ingredients. The Panel concluded that centella asiatica extract, centella asiatica callus culture,

centella asiatica flower/leaf/stem extract, centella asiatica leaf cell culture extract, centella asiatica leaf extract, centella

asiatica leaf water, centella asiatica meristem cell culture, centella asiatica meristem cell culture extract, and centella asiatica

root extract are safe in the present practices of use and concentration in cosmetics, as described in this safety assessment,

when formulated to be non-sensitizing.

INTRODUCTION

The safety of the following 9 ingredients in cosmetics is reviewed in this safety assessment:

• centella asiatica extract

• centella asiatica callus culture

• centella asiatica flower/leaf/stem extract

• centella asiatica leaf cell culture extract

• centella asiatica leaf extract

• centella asiatica leaf water

• centella asiatica meristem cell culture

• centella asiatica meristem cell culture extract

• centella asiatica root extract

These ingredients function primarily as skin conditioning agents in cosmetic products.

A detailed list of Centella asiatica-

derived ingredient functions is included in Table 1.

CHEMISTRY

Definition and Characterization

Centella asiatica (hydrocotyle; Indian pennywort) is a herbaceous plant of the Apiaceae family.

The definitions

and functions, in cosmetics, of the Centella asiatica-derived ingredients reviewed in this safety assessment are presented in

Table 1.

Physical and Chemical Properties

Centella Asiatica Extract

Properties of a material described as a hydroglycolic (propylene glycol/water) extract of Centella asiatica are

presented in Table 2.

Method of Manufacture

Centella Asiatica Extract

In the production of centella asiatica extract, the stalks and leaves of Centella asiatica are macerated in propylene

glycol and water for several days. The material is then drained and pressed, followed by a sterilizing filtration.

According to another source, the dried raw material (Centella asiatica) is extracted with an 80% propylene glycol

solution or with ethanol.

For the propylene glycol extract, extraction is followed by filtration, sedimentation, filtration, and

packaging. For the ethanol extract, extraction is followed by filtration, concentration, sedimentation, filtration, and

packaging.

The methanolic extract of Centella asiatica has been prepared as follows:

The whole plant was washed, dried, and

powdered. The dry powder (5 g) was extracted with 50 ml of 80% methanol, the extract was filtered, and the filtrate was

evaporated to dryness in a vacuum. The yield of the solvent free extract was 20% (i.e., 1 g).

Centella Asiatica Leaf Extract

Centella asiatica leaf extract has been prepared as follows:

The Centella asiatica plant was cleaned with triple-

distilled water and the leaves were separated and freeze-dried. The leaves were boiled in triple-distilled water, and the extract

was then lyophilized and stored at -80°C.

According to another method, the fresh leaves of the Centella asiatica plant are air-dried at 40˚C and ground to

powder, which is then subjected to exhaustive extraction using ethanol in a Soxhlet apparatus.

The dark-green liquid extract

is concentrated under vacuum, and the resulting dried extract is lyophilized and preserved in a refrigerator at 4˚C.

Centella Asiatica Meristem Cell Culture

Centella asiatica meristem culture is obtained from a cell culture of Centella asiatica consisting of a population of

undifferentiated stem cells originating from leaves.

The cells are then filtered in order to remove the culture medium.

Glycerin is added to the cells, which results in extraction of the internal soluble substances and the external cell walls (largely

insoluble in water and solvents).

Composition/Impurities

Centella Asiatica Extract

Centella asiatica plant extract consists of the following:

• plant sterols

• flavonoids

• tannins (20 to 25%)

• essential acid (0.1% with β-chariophylen, trans-β-pharnesen, and germachrene D)

• phytosterols (campesterol, sitosterol, stigmasterol)

• mucilages

• resins

• free amino acids (alanine, serine, aminobutyrate, aspartate, glutamate, lysine, and threonine)

• flavonoids (derivatives of chercetin and kempferol)

• an alkaloid (hydrochotine)

• vallerine

• fatty acids (linoleic, linolenic, oleic, palmitic, and stearic acids)

According to another source, both the ethanol and propylene glycol extracts of Centella asiatica contain tannins and

saponins.

The following specifications for impurities relate to a material described as a hydroglycolic (propylene glycol/water)

extract of Centella asiatica (dry extract: 1.0 to 5 g/100g): heavy metals content (Pb) (< 20 ppm), arsenic (< 1 ppm), and

total aerobic germs (< 100/g).

Centella asiatica

The composition of Centella asiatica has been described to include:

11,12

• asiaticoside*

• centelloside*

• madecassoside*

• asiatic acid*

• volatile oils

• flavonoids

• tannins

• phytosterols

• amino acids

• sugars

• centellin (6-acetoxy-trideca-1,7-dien-4-yn-3-ol)

• asiaticin (p-benzoyloxy methyl-butyl benzoate)

• centellicin (1-(2',3'-dihydroxypropyl)-2-en-3-methyl-6-hydroxy-9-yn-undecanoate)

The most important constituents isolated from Centella asiatica were triterpenoid saponins known as centelloids

(identified by an asterisk above). Chemical structures of triterpenoid saponins are presented in Figures 1, 2, and 3.

13,14

Figure 1. Asiaticoside and Asiatic Acid

Figure 2. Madecassoside and Madecassic Acid (difference from Asiaticoside and Asiatic Acid in red)

Figure 3. Centellosides

Saponins may account for 1% to 8% of all Centella asiatica constituents.

The variable quantity of saponins

depends mainly on the origin of the plant and can be established by high-performance liquid chromatography with an

ultraviolet detector (HPLC-UV). Other constituents of Centella asiatica, identified as centellosides, are primarily ursane-

and oleanane-type pentacyclic triterpenoid saponins. The pharmacological activity (e.g., treatment of venous hypertension)

of the centellosides is attributed to the compounds asiaticoside, madecassoside, asiatic acid, and madecassic acid.

Asiaticoside also induces type I collagen synthesis and stimulates angiogenesis. Other centellosides occurring in Centella

asiatica include triterpenic acids (e.g., brahmic acid, madasiatic acid, terminolic acid, centellic acid) as well as their

glycosides, namely, brahminoside, madasiaticoside and centelloside. Centella asiatica also contains volatile oils (0.1%).

Thin layer chromatography analyses of the root, stem, leaves, and petioles of Centella asiatica for alkaloid,

flavonoid, terpenoid, and saponin components indicated that these plant parts are similar in terms of their composition, and

that the greatest concentration of components is found in the leaf.

16,17

The results of a systematic review of the chemical

constituents of Centella asiatica (including the whole plant, aerial parts, leaves, root, stem, and petioles) grown in various

countries (United States, Europe, and Asia [majority of data from Asia]) indicated that triterpenes are the components that

were consistently identified. The triterpenes identified were mainly pentacyclic triterpenes, belonging to ursane- or oleanane-

type, including asiaticoside, madecassoside, asiatic acid, and madecassic acid.

In the Centella asiatica plant, grown in peninsular Malaysia, barium concentrations (μg/g dry weight) ranged from

5.05 to 21.88 μg/g in roots, 3.31 to 11.22 μg/g in leaves, and 2.37 to 6.14 μg/g in stems.

This study was performed because,

at the time, there was no established background level of barium in soils and in edible Centella asiatica for Malaysia.

Centella Asiatica Meristem Cell Culture

and Centella Asiatica Callus Culture

Centella asiatica meristem culture is composed mainly of primary metabolites (lipids, glucides (carbohydrates), and

amino acids).

Only traces of secondary metabolites are detected. Saponin derivatives from asiatic and madecassic acids

have never been detected in this product. The total control of culture conditions guarantees the absence of environmental

contaminants such as pesticides, heavy metals, and biological pollutants. Centella asiatica meristem cell culture and centella

asiatica callus culture are basically the same in terms of their composition.

USE

Cosmetic

The safety of Centella asiatica-derived ingredients is evaluated based on the expected use of these ingredients in

cosmetics. The Panel uses data received from the Food and Drug Administration (FDA) and the cosmetics industry to

determine expected cosmetic use. Use frequencies of individual ingredients in cosmetics are collected from manufacturers

and reported by cosmetic product category in FDA’s Voluntary Cosmetic Registration Program (VCRP) database. Use

concentration data are submitted by Industry in response to surveys of maximum reported use concentrations, by product

category, that are conducted by the Personal Care Products Council (Council). Collectively, the use frequency and use

concentration data indicate that 4 of the 9 Centella asiatica-derived ingredients are used in cosmetic products.

21,22

According

to these data, the following 5 ingredients are not being used in cosmetics:

centella asiatica callus culture

centella asiatica leaf cell culture extract

centella asiatica leaf water

centella asiatica meristem culture extract

centella asiatica root extract

According to the 2015 VCRP, the greatest reported use frequency is for centella asiatica extract (454 formulations,

mostly leave-on), followed by centella asiatica leaf extract (66 formulations, mostly leave-on) (Table 3).

Lower use

frequencies are reported for the remaining Centella asiatica-derived ingredients. The results of a concentration of use survey

conducted by the Personal Care Products Council (Council) and provided in 2015 indicate that centella asiatica extract has

the highest maximum concentration of use; it is used at concentrations up to 0.5% in leave-on products (face and neck

products [not spray]) (Table 3).

Cosmetic products containing Centella asiatica-derived ingredients may be applied to the skin and hair or,

incidentally, may come in contact with the eyes and mucous membranes. Products containing these ingredients may be

applied as frequently as several times per day and may come in contact with the skin or hair for variable periods following

application. Daily or occasional use may extend over many years.

Centella asiatica extract is reported as being used in face powders that may be loose powder products (but not spray

products), and could possibly be inhaled. Industry can minimize airborne particles from cosmetic powder products by

controlling the milling of the ingredients and adding binding materials, such as oils, waxes or hygroscopic ingredients, in the

formulations.

The binding materials foster the agglomeration of the ingredients and substantially increase their

cohesivity. These measures increase the size of the particles in the product, and can ensure that airborne particles produced

during the use of such products are not respirable to any appreciable amount.

Noncosmetic

Centella asiatica

The herb Centella asiatica (also known as gotu kola) has been used in traditional Asian medicine for many years,

especially to treat dermatological conditions, including small wounds, scratches, and burns, and as a hypertrophic wound

healing agent and an anti-inflammatory agent, particularly in eczema.

However, gotu kola, centella asiatica extract, and an

ointment that contains centella asiatica extract (Madecassol ointment) are not included in FDA’s database of FDA-approved

drug products.

Centella Asiatica Extract

The extract from the fresh and dried leaves and stems of Centella asiatica contains triterpenic derivatives

(madecassic acid, asiatic acid, and asiaticoside), which have been shown to promote epithelialization and have anticellulitic

and vasotonic activity.

According to another source, the active principle of Centella asiatica is a triterpenic derivative, from

which a glycolic extract is obtained.

Reportedly, this glycolic extract is used widely, topically in dermatology, to promote

the epithelialization of wounds and ulcers, and as an anticellulitic and vasotonic. Information relating to the underlying

mechanism(s) for centella asiatica extract in keloid management/wound healing is included in the section on Other Effects.

Centella asiatica preparations are used as drugs in Europe. The European Medicines Agency reports that, for

cutaneous use in the treatment of leg ulcers, wounds, and burns, etc., ointments contain 1% titrated extract of Centella

asiatica (TECA). A cutaneous powder containing 2% TECA is used for the treatment of scars, keloid scars, and burns.

TOXICOKINETICS

Non-Human

Centella asiatica

The disposition and metabolism of madecassoside (see Figure 2), one of the major triterpenoid saponins present in

Centella asiatica, was evaluated using groups of 6 Sprague-Dawley rats.

The test substance was administered orally at a

single dose of 100 mg/kg. Plasma, heart, liver, spleen, lung, kidney, and brain tissues, and bile, urine and feces were

collected from 0 h to 72 h post-dosing. Madecassoside concentrations in biological samples were determined using liquid

chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS). After oral dosing, madecassoside was widely

distributed to the heart, liver, spleen, lung and kidney of rats, and the concentrations of madecassoside in liver and kidney

were relatively higher than in other organs. Values for the excretion of madecassoside in bile, urine, and feces were 7.16%

(0-12h), 0.25% (0-72h) and 24.68% (0-72h) of the administered dose, respectively. Madecassoside was metabolized by

hydrolase isozymes produced by intestinal bacteria, and the following 3 deglycosylated metabolites identified in rat feces

were consistent with the sequential cleavage of C-28 glycoside bonds: O-glucopyranosyl(1,6)-glucopyranosyl-2,3,6,23-

tetrahydroxyurs-12-en-28-oate; O-glucopyranosyl-2,3,6,23-tetrahydroxyurs-12-en-28-oate, and madecassic acid.

Human

Centella Asiatica Extract

Following a single 30 mg and 60 mg oral dose of centella asiatica extract administered to 12 human subjects,

maximum plasma levels of asiatic acid were attained in 4.5 h and 4.2 h, respectively.

11,29

Plasma half-lives were 2.2 h (30 mg

dose) and 3.4 h (60 mg dose), with no detectable levels of the saponin in plasma 24 h post-dosing. The same doses of

centella asiatica extract administered orally for 7 days resulted in higher peak plasma concentrations, longer half-lives, and

greater area-under-the-curve values. The authors noted that the 3 principal components of the triterpenoid fraction (TTF) of

Centella asiatica are asiatic acid, madecassic acid, and asiaticoside. Furthermore, asiatic and madecassic acids together

account for approximately 60%, and asiaticoside accounts for 40% of the composition of TTF.

TOXICOLOGY

Acute Toxicity

Oral

Non-Human

Centella Asiatica Leaf Extract

The acute oral toxicity of centella asiatica leaf extract was evaluated using groups of 8 adult Wistar albino male

rats.

The test substance was administered orally (intubation) at a single dose of 100, 500, 1000, or 2000 mg/kg. The LD

was 200 mg/kg (calculated value). Additional study details were not included.

Repeated Dose Toxicity

Oral

Human

Centella Asiatica Extract

A study was performed to evaluate the safety and clinical efficacy of centella asiatica extract (plant part and

extraction method not specified) oral administration and identify any side effects.

The study involved 84 diabetic wound

patients receiving oral doses of the extract and a placebo group consisting of 86 patients (mean age = 59 years, all patients).

Two centella asiatica extract capsules (50 mg of extracted asiaticoside/capsule) were taken after a meal 3 times per day for 21

days. Centella asiatica extract capsules promoted the wound healing process (rapid wound contraction), when compared to

the placebo group. No systemic side effects or complications were reported.

REPRODUCTIVE TOXICITY

Centella Asiatica Leaf Extract

The reproductive toxicity of centella asiatica leaf extract (in distilled water) was evaluated using 5 groups of 8

Wistar adult male rats.

Four groups received oral doses (gavage; dose volume = 1 ml) of 10, 50, 80, and 100 mg/kg/day,

respectively, for 8 weeks. The fifth group was given distilled water and served as the control. Animals were killed on the last

day of dosing (day 60). When compared to the control group, statistically significant (p < 0.01 or p < 0.001) reductions in

sperm viability and motility were noted in each group dosed with centella asiatica leaf extract. In each experimental group,

histopathological examination of the testis revealed a significant (p value not stated) decrease in the number of spermatogenic

cells (spermatogonia, spermatocyte, spermatid, and sperm) in the seminiferous tubules. Also, when compared to the control

group, intertubular spaces and venous congestion were increased in experimental groups. The authors noted that the reported

loss in testicular weight likely corresponded to a dose-dependent decrease in mean spermatogenic cells in seminiferous

tubules. At the 100 mg/kg/day dose, the mean number of sperms from the cauda epididymis (x 10

) was 36.7 ± 4.8,

compared to a mean value (control) of 61.60 ± 2.34; this difference was statistically significant (p < 0.001). Additionally,

degeneration of seminiferous tubules was reported. It was concluded that centella asiatica leaf extract was toxic to the

reproductive system of male rats.

Centella Asiatica Extract

A study was performed to evaluate the effects of centella asiatica extract (ethanol extract) on the rat testis.

The

following groups of 8 male Sprague-Dawley rats (dosed orally) were used in the study: low-dose group (100 mg/kg body

weight), mid-dose group (200 mg/kg body weight), high-dose group (300 mg/kg body weight), and control group (distilled

water). The groups were force fed (using force feeding needle) for 42 consecutive days, after which the animals were killed

and the testis removed for histological examination. Animals of all dose groups had some degeneration of spermatogenic

cells and reduction of spermatozoa in the lumen of the seminiferous tubules. When compared to the control group, the serum

testosterone level decreased in a dose-dependent manner and there was a significant decrease in cauda epididymal sperm

count. A statistically significant reduction (p < 0.05) in sperm count was observed in the 200 mg/kg and 300 mg/kg dose

groups, but not in the 100 mg/kg dose group. Differences in sperm motility were also observed. Slow or sluggish

progressive sperm motility was reported for the control and 100 mg/kg dose group. Non-progressive motility (< 5

µm/second) was reported for both the 200 mg/kg and 300 mg/kg dose groups. In control animals, the testis had normal

features, with successive stages of transformation of the seminiferous epithelium into spermatozoa. However, abnormalities

in seminiferous tubules were observed in all dose groups. Complete arrest of the seminiferous tubules was observed only in

the 300 mg/kg dose group. It was concluded that centella asiatica extract (ethanol extract) was a reproductive toxicant in

male rats.

GENOTOXICITY

In Vitro Assays

Centella Asiatica Leaf Extract

The genotoxicity of centella asiatica leaf extract (acetone extract) was evaluated in a chromosomal aberration assay

using human peripheral blood lymphocytes.

Results were negative over the range of test concentrations (1.075 x 10

-4

4.17 x 10

-4

g/ml). Results for the dimethylsulfoxide (DMSO, 5 µl/ml) control were negative. A sister chromatid exchange

assay was also used to evaluate the genotoxicity of the same test substance using human peripheral blood lymphocytes.

Results were negative over the same concentration range tested in the chromosomal aberration assay. Again, results for the

DMSO control were negative.

Centella Asiatica Extract

The genotoxicity of centella asiatica extract (aqueous extract of edible plant parts) was evaluated in the Ames test

using Salmonella typhimurium strains TA98 and TA100.

The extract was tested, with and without metabolic activation, at

concentrations of 2 and 5 mg/plate. Results were uniformly negative.

Centella Asiatica Meristem Cell Culture

The genotoxicity of centella asiatica meristem cell culture (20% cells, 80% glycerin) was evaluated in the Ames test

at doses up to 100 mg/plate using the following bacterial strains, with and without metabolic activation:

Salmonella

typhimurium strains TA1535, TA1537, TA98, TA100, and TA102. Negative control cultures with and without solvent

(water) were used. The positive controls without metabolic activation were as follows: sodium azide, 9-aminoacridine, 2-

nitrofluorene, and mitomycin C. 2-Aminoanthracene and cyclophosphamide served as positive controls with metabolic

activation. The test material was not genotoxic in any of the strains tested, with or without metabolic activation. The

positive controls were genotoxic.

CARCINOGENICITY

Data on the carcinogenicity of Centella asiatica-derived ingredients were not found in the published literature and

unpublished data were not submitted.

Asiaticoside

The dermal carcinogenicity of asiaticoside was evaluated using groups of hairless mice (males and females).

The

test substance was painted on dorsal skin twice weekly during the lifetime of the animals, up to 2 years. A group of 29 mice

was intiated with 20-methylcholanthrene (MCA) and, 14 days later, painted twice weekly with 0.1% asiaticoside in benzene.

Mice from a second group of 28 were painted with asiaticoside (0.1% in benzene) twice weekly, but were not initiated with

MCA. Additionally, 34 control mice were initiated with MCA and subsequently (after 14 days) painted with benzene twice

weekly. After the skin was painted with asiaticoside, the tumor yield was 3.4% with MCA initiation (1 malignant tumor in

29 mice) and 2.5% without MCA initiation (1 malignant tumor in 128 mice). Both of the tumors observed were sarcomas of

the dermis, and carcinomas were not found. Asiaticoside (0.1% in benzene) did not cause necrosis or acantholysis of the

skin. The tumor yield in mice painted with benzene after MCA initiation was 2.9% (1 carcinoma in 34 mice). However, the

authors noted that benzene is not carcinogenic to the skin and, in a later control series with benzene painting alone, caused

very small benign papillomas in 7.3% of the animals during the same observation time.

In the MCA-initiated group treated with asiaticoside, the number of male mice with papillomas was higher

(compared to control group) during the entire observation period and significantly higher (p < 0.05) during the last

observations. In the control group (painted with benzene after MCA initiation), the number of mice with papillomas

increased rapidly from the 6

to 14

month of the study, then declined gradually. Without initiation, the number of mice

with papillomas increased more slowly, but parallel with the group treated with asiaticoside after MCA initiation. The values

for papilloma tumor yield without MCA initiation were 64.2% (asiaticoside) and 7.3% (benzene). After skin painting with

asiaticoside + MCA initiation, a 28% incidence of reticuloses and malignant lymphomas was reported; a 36% incidence was

reported for the non-initiated group. The reticuloses and malignant lymphomas tumor incidence was not significantly

different when compared to the control group treated with benzene after MCA initiation. It was concluded that asiaticoside

can be classified as a weak tumor promoter in the hairless mouse epidermis, and also seems to be very weakly carcinogenic

to the dermis by surface application to the skin.

IRRITATION AND SENSITIZATION

Dermal

Non-Human

Centella Asiatica Extract

The skin irritation threshold of centella asiatica extract, in emulsion prepared from Freund’s complete adjuvant

(FCA) and physiological saline, was determined using 10 guinea pigs (test protocol not included).

Unprocessed dry leaves

of Centella asiatica were extracted with diethyl ether and ethanol. The irritancy threshold of the extract was determined to be

greater than 30%.

The skin sensitization potential of 30% centella asiatica extract (extracted with diethyl ether and ethanol) was

evaluated in the guinea pig maximization test using 10 female guinea pigs.

The extract (30 mg in FCA and saline) was

injected intradermally into the shoulder area. Following an 11-day non-treatment period, the animals were challenged on day

20. During the challenge phase, centella asiatica extract (30%), dissolved in a mixture of acetone/ethanol (1:1), was applied

epicutaneously (open) to skin of the right flank. The following reactions, scored in accordance with International Contact

Dermatitis Research Group criteria, were reported: seven + reactions (at 24 h reading), three + reactions (at 48 h reading),

and two + reactions (at 72 h reading). Centella asiatica extract was classified as a weak sensitizer in this study.

In another study, the skin sensitization potential of TECA (ethanol extract) was evaluated using 10 guinea pigs

(strain not stated), according to OECD protocol 406.

A negative control group was included; however the number of

animals was not stated. The induction phase consisted of topical applications of undiluted TECA. Following a 17-day non-

treatment period, the animals were challenged with undiluted TECA and 50% TECA in paraffin oil (each under an occlusive

dressing for 24 h). The test substance (on 2 x 4 cm filter paper) was applied to the flank. No macroscopic cutaneous

reactions attributable to allergy were observed during the challenge phase. Similarly, no cutaneous intolerance reactions

were observed in the negative control group.

Human

Centella Asiatica Extract

Negative patch test results were reported for 20 subjects patch tested with centella asiatica extract at concentrations

of 1% and 5% in petrolatum.

These 20 subjects comprised the control group in a case report (42-year old patient) on

centella asiatica extract that is summarized later in the report text.

The skin sensitization potential of a cream containing 0.045% centella asiatica extract was evaluated in a human

repeated insult patch test (HRIPT) involving 110 subjects.

The undiluted test material was applied to the skin (location and

area not stated) using an occlusive patch for a total of 9, 48-h induction applications. The challenge phase was initiated

12 to 24 days after application of the last induction patches. Challenge patches were applied for 48 h to original and new test

sites, and reactions were scored at approximately 48 h and 96 h post-application. The cream did not induce allergic contact

dermatitis in any of the subjects tested.

In another HRIPT, the skin irritation and sensitization potential of a body cream containing 0.018% centella asiatica

extract was evaluated using 52 subjects (17 men, 35 women).

The cream (~ 0.2 ml) was applied to the back using an

occlusive patch (2 cm x 2 cm), for a total of 9, 24-h induction applications. Following a 10- to 14-day non-treatment period,

a challenge patch was applied for 24 h to a new site on the opposite side of the back. Transient, barely perceptible erythema

to mild erythema was observed in 17 of 52 subjects (33%) during induction and/or challenge phases of the study. However,

the reactions observed were considered neither evidence of clinically meaningful irritation nor allergic in nature.

Centella Asiatica Flower/Leaf/StemExtract

A cleanser containing 0.01% centella asiatica flower/leaf/stem extract was evaluated in an HRIPT involving 112

male and female subjects.

A 3% dilution of the cleanser was tested (effective concentration = 0.01% x 3% = 0.0003%).

Using a semi-occlusive patch (1" x 1"), 0.2 g of the diluted cleanser was applied to the upper back for a total of 9, 24-h

induction applications. A 2-week non-treatment period was observed, and a challenge patch was applied to a new test site.

Challenge reactions were scored at 24 h and 72h post-application. The test material did not induce dermal irritation or allergic

contact dermatitis in any of the subjects tested.

Centella Asiatica Leaf Extract

The skin irritation and sensitization potential of an eye lotion containing 0.2% centella asiatica leaf extract was

evaluated in an HRIPT using 54 subjects (men and women).

An occlusive patch containing approximately 0.1 g to 0.15 g

of the lotion (≈ 25 to 38 mg/cm

) was applied to the back (between the scapulae and waist, adjacent to the spinal midline) of

each subject. This procedure was repeated for a total of 9, 24-h induction applications. Following a 2-week non-treatment

period, a challenge patch was applied to a new site. Reactions were scored at 24 h and 72 h post-application. The lotion did

not cause skin irritation or allergic contact dermatitis in any of the subjects tested.

In a patch test (contact or epicutaneous test) for evaluating skin irritation potential, an eye cream containing 0.1%

centella asiatica leaf extract (dose = 0.05 g/cm

) was applied to the backs of 68 male and female subjects (18 to 70 years

old).

Patches (filter paper disc) remained for 48 h, and reactions were scored at 30 minutes and 24 h after patch removal.

Skin irritation was not observed in any of the subjects tested. In an HRIPT (same subjects), an eye cream containing 0.1%

centella asiatica leaf extract (0.05 g/cm

) was applied to the back using a filter paper disc. The procedure was repeated for a

total of 10, 24-h applications. Following a 10-day non-treatment period, a challenge patch was applied to a new site on the

back. Challenge reactions were scored at approximately 30 minutes and 24 h after patch removal. The test material did not

induce skin irritation or sensitization in any of the subjects tested.

Centella Asiatica Meristem Cell Culture

The skin irritation and sensitization potential of centella asiatica meristem cell culture (20% in glycerol) was

evaluated in an HRIPT involving 108 subjects (mean age = 49 years). The test substance was applied at a concentration of

30% in distilled water (effective concentration = 6%) during induction, but was tested undiluted during the challenge phase.

The dose per cm

was not stated. During induction, the diluted test substance was applied (under a semi-occlusive patch) to

the same site nine times over a period of 3 consecutive weeks. Following a 2-week non-treatment period, the undiluted test

substance was applied to the induction site and to a new site. Distilled water was applied (in parallel) to a control site

according to the same test procedure. Neither skin irritation nor sensitization was observed during the study.

Centella Asiatica Root Extract

A material with the following composition was evaluated for skin irritation and sensitization potential in 47 subjects:

centella asiatica root extract, as % solid content in overall extract composition (0.1%), water (98.3%), potassium sorbate and

phenoxyethanol preservative blend (0.6%), and Saccharomyces lysate extract (0.1%).

The preceding repeated insult patch

test procedure was used. The test material did not cause dermal irritation or allergic contact sensitization in any of the

subjects tested.

Madecassoside

The skin irritation and sensitization potential of a mascara containing 0.5% madecassoside (component of Centella

asiatica) was evaluated using 109 adults.

All 109 subjects were evaluated for primary skin irritation potential. The

numbers of subjects who were available for the evaluation of cumulative irritation and sensitization potential were 104 and

102, respectively. The test material (0.2 g) was applied over a 50 mm

area of the back using an occlusive patch (Finn

chamber). This procedure was repeated for a total of 9 induction applications over a 3-week period. The patch application

period for the 1

, 2

, 4

, 5

, 7

, and 8

inductions was 48 ± 4 h. A 72 ± 4-h patch application period was observed on

induction days 3, 6, and 9. The challenge phase was initiated after a 13-day non-treatment period. A challenge patch was

applied for 48 ± 4 h to a new site and the previously patch-tested site. Challenge reactions were scored between 30 to 35

minutes and 48 ± 4 h after patch removal. Neither primary nor cumulative skin irritation was observed during induction

(mean irritation index = 0.01 [non-irritant]). Skin sensitization reactions were not observed during the challenge phase. The

authors concluded that the product did not cause primary or cumulative skin irritation or sensitization.

Case Reports

Centella Asiatica Extract (from leaf and stem)

Erythema and mild eczematous lesions were observed on keloid skin of a 33-year-old woman after application of an

ointment that contained Centella asiatica (composition described below).

Patch test results were positive (++) for this

ointment. The area of the application site and patch test protocol were not stated.

• TECA (1g)*

• Asiaticoside (0.4 g in TECA)*

• Asiatic acid (0.3 g in TECA)*

• Madecassic acid (0.3 g in TECA)*

• Glycol stearate (15 g)

• Propylene glycol (30 g)

• White Vaseline (5 g)

• Lavender oil (0.143 ml)

• Geranium oil (0.143 ml)

*TECA (1 g) contains Asiaticoside (0.4 g) + Asiatic Acid (0.3 g) + Madecassic Acid (0.3 g).

Negative patch test results were reported for TECA at concentrations of 1% and 10% in petrolatum. In a second case report,

a 23-year-old woman applied the same ointment on the donor site of her skin graft and itchy, oozing erythematous lesions

were observed. Patch test results were positive for the following materials: 10% TECA, the ointment, propylene glycol

(20%, 30%, 40%, and 50%), and geranium oil (20%).

According to comments on these test results that were received from

the cosmetics industry, the ointment tested contains excipients such as lavender oil and geranium oil, which are known to be

allergenic.

Localized, severe eczema on the neck and upper chest was observed in a 42-year-old non-atopic woman after

treatment of a scar with the ointment that is described earlier in this section.

Patch test results were positive for the

ointment and centella asiatica extract (extraction method not specified) at concentrations of 1% and 5% in petrolatum.

A case of allergic contact dermatitis in a 54-year-old woman, with no history of atopic or allergic contact dermatitis,

after application of an ointment containing centella asiatica extract was reported.

The patient was patch tested with centella

asiatica extract (1% and 10% in petrolatum; and 2% in ethanol 70˚ [70˚ = alcohol proof]). Patch testing with the 1% centella

asiatica extract resulted in a + reaction at 48 h and a ++ reaction at 72 h and 96 h. A +++ reaction to 2% and 10% centella

asiatica extract was observed at 48 h, 72 h, and 96 h.

Centella Asiatica Extract

A 42-year-old woman, with no history of atopy, developed severe dermatitis of the legs after application of a

vasotonic cream containing centella asiatica extract (2% in alcohol 70˚).

The extraction method was not specified. The

patient was patch tested using the Finn Chamber

and thin-layer rapid-use (TRUE) test

methods. Reactions were scored at

2 and 4 days. A +++ reaction to centella asiatica extract was reported.

A red vesicular reaction, with exudation and intense itching, was observed in a 39-year-old woman after applying a

cream containing centella asiatica extract (concentration in cream not stated).

The extraction method was not specified.

Patch testing with the cream yielded a +++ reaction. Patch testing with centella asiatica powder (1% in petrolatum) yielded a

+++ reaction on days 2 and 3. However, negative reactions were observed in 50 control subjects patch tested with 1%

centella asiatica powder in petrolatum.

An eczematous reaction on both knees of a 38-year-old man with joint pain was observed after topical application of

a cream that contained centella asiatica extract (concentration not stated).

The extraction method was not specified. Patch

test results for centella asiatica extract were positive (+++ reaction).

Centella asiatica

Three women (61, 52, and 49 years old) developed jaundice after taking Centella asiatica tablets (for weight loss)

during 30, 20, and 60 days, respectively.

Neither the dose of Centella asiatica per tablet ingested nor the number of tablets

ingested per day was stated. The respective diagnoses were: granulomatous hepatitis with marked necrosis and apoptosis;

chronic hepatitis with cirrhotic transformation and intense necroinflammatory activity; and granulomatous hepatitis. All three

cases recovered after discontinuing use of these tablets.

Ocular Irritation

In Vitro

Centella Asiatica Leaf Extract

The ocular irritation potential of an eye lotion containing 0.2% centella asiatica leaf extract was also evaluated using

a three-dimensional human corneal epithelial (HCE) model.

The model consisted of human corneal cells cultured on an

inert polycarbonate filter at the air-liquid interface. The objective of this assay was to assess, quantitatively, the effects of the

test material on cell survival through the 4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.

Determination of cell viability was based on cellular dehydrogenase activity, which was measured by MTT reduction and

conversion into blue formazan salt (quantified after extraction from tissues). The reduction of cell viability was compared to

the negative control (phosphate-buffered saline) and expressed as a percentage. The percentage reduction in cell viability

was used to predict ocular irritation potential. The time to toxicity (ET

; MTT activity reduced to 50% of the control

condition) was determined.

The eye lotion directly reduced MTT in this study, and, therefore, a killed-control experiment (functional check

using freeze-killed control tissue) was performed to evaluate whether residual test article was binding to the tissue and

causing a false MTT reduction signal. The results of the killed control experiment indicated that there was little or no direct

MTT reduction in the test material-treated killed control, compared to the negative control-killed controls, and the MTT

reduction in the test material-treated viable tissue was ascribed to the viable cells. An ET

of 21.5 h was reported for the eye

lotion, and an ET

of 28.2 minutes was reported for the 0.3% Triton-X-100 positive control. The meaning of these reported

values in terms of irritation potential was not stated.

Centella Asiatica Meristem Cell Culture

A raw material for use in cosmetic products ( liquid containing glycerol [80%], centella asiatica (Apiaceae) cells

[20%], xanthan gum [0.3%]) was evaluated for ocular irritation potential using the HCE model and MTT assay that are

described in the preceding study.

The test material was considered a non-irritant.

Centella Asiatica Root Extract

The following material (diluted with distilled water to 1%; data extrapolated to 5%) was evaluated for ocular

irritation potential using the HCE model and MTT assay:

centella asiatica root extract, as % solid content in overall extract

composition (0.8% to 1.2%), water (97% to 98%), phenoxyethanol (1%), and sodium benzoate (0.3%). The ET

was

greater than 256 minutes. Therefore, at 5%, the estimated Draize ocular irritation score for the test material was 0 (non-

irritating).

OTHER EFFECTS

Wound Healing

Centella Asiatica Extract

The active ingredients of centella asiatica extract in the process of wound healing are the triterpenoid compounds

asiatic acid, madecassic acid, asiaticoside, and madecassoside.

Centella asiatica extract has a history of use in keloid management (i.e., anti-scar activity), and asiatic acid is one of

the extract’s principal bioactive components.

Keloids are fibroproliferative lesions characterized by exuberant extracellular

matrix deposition. Furthermore, keloid formation, a result of abnormal wound healing, is characterized as exuberant collagen

deposition and invasive growth beyond original wound margins. The transforming growth factor (TGF)-β/Smad pathway

plays a pivotal role in keloid pathogenesis. In an in vitro assay, asiatic acid inhibited TGF-β1-induced collagen and

plasminogen activator inhibitor-1 (PAI-1) expression in keloid fibroblasts through peroxisome proliferator-activated

receptor- γ (PPAR-γ) activation. Thus, asiatic acid inhibited collagen type I expression in keloid fibroblasts. The authors

noted that this finding suggests that asiatic acid was one of the active constituents of Centella asiatica responsible for success

in keloid management.

Human foreskin fibroblast cells were incubated with centella asiatica extract (100 µg/ml) for 48 h.

The extraction

method was not specified. Centella asiatica extract stimulated collagen and fibronectin synthesis in fibroblasts. When

compared to control cultures, collagen synthesis was statistically significantly increased (p < 0.05) and fibronectin synthesis

was elevated by approximately 1.5-fold.

Centella Asiatica Leaf Extract

Following oral and topical administration of Centella asiatica (1 ml of crude leaf extract) in rats, increased cellular

hyperplasia and collagen production were observed at the site of injury in a wound healing assay. The following served as

measurements of increased cellular hyperplasia and collagen production: increased levels of DNA, protein, total collagen,

and hexosamine in granulation tissue. More rapid maturation and cross-linking of collagen were observed in animals treated

with centella asiatica extract (10% to 15%), as determined by elevated stability of acid-soluble collagen and increases in

aldehyde content and tensile strength. When compared to control wounds, rats treated with Centella asiatica had a higher

degree of epithelialization and a higher rate of wound contraction.

11,56,57

Effect on Mucopolysaccharide Metabolism

Centella asiatica

Individuals with varicosities receiving (mode of administration not stated) 30 mg total triterpenoid fraction of

Centella asiatica twice daily for 3 months had significantly reduced levels of serum enzymes involved in

mucopolysaccharide metabolism (beta-glucuronidase, beta-N-acetylglucosaminidase, and arylsulfatase), compared to

baseline values (p < 0.01).

11,58

Effect on Nerve Regeneration

Centella Asiatica Extract

Following a sciatic nerve crush injury, male Sprague-Dawley rats given centella asiatica extract (ethanol extract) in

drinking water (300 to 350 mg/kg daily) for 18 days recovered more quickly from this nerve damage, compared to controls.

Increased axonal regeneration and more rapid functional recovery were observed.

11,59

It should be noted that dried centella

asiatica extract (ethanol extract) was dissolved in drinking water at a concentration of 2 mg/ml. Based on the amount of

water that was consumed, the average dose for each rat was calculated to be 300 to 350 mg/kg daily over the 18-day study.

The authors noted that the capacity to regenerate axons is an important component of healing after nerve damage.

Cytotoxicity

Centella Asiatica Leaf Extract

The cytotoxic activity of centella asiatica leaf extract (aqueous extract) against four cancer cell lines and one normal

cell line was studied using the MTT assay, a colorimetric assay for assessing cell viability.

Cultures were incubated with

centella asiatica leaf extract at concentrations ranging from 0.1 to 1000 μg/ml. The 50% inhibitory concentrations (IC

) were

calculated by linear regression over the range of test concentrations. Centella asiatica leaf extract was cytotoxic to the

following cancer cell lines: human breast cancer MDA-MB 231 (IC

= 648 µg/ml), mouse melanoma B16F

(IC

= 698

µg/ml), and rat glioma C6 (IC

= 1,000 µg/ml). The leaf extract was not cytotoxic at concentrations up to 1,000 μg/ml to the

human lung carcinoma (A549) and normal hamster kidney (BHK-21) cell lines.

Centella Asiatica Extract

The potential for centella asiatica extract (methanolic extract of whole plant) to induce apoptosis was evaluated in

the following cancer cell lines: MCF-7, HeLa, HepG2, and SW 480.

In the manufacturing process, the yield of the solvent

free extract was 20% (i.e. 1 g). In cell viability assays, cells grown in 96-well microtitre plates (7000 cells/well) were

incubated for 48 h with and without centella asiatica extract (10.5 to 82 μg/100 µL). The MCF-7 cell line was found to be

most sensitive to in vitro growth inhibitory activity. Centella asiatica extract inhibited proliferation of the MCF-7 cell line in

a concentration-dependent manner (LD

= 66 µg [calculated value]). The highest test concentration of the extract (82

µg/100 µL) inhibited MCF-7 cell growth to an extent that was almost equivalent to tamoxifen (10 mM)-induced inhibition.

Centella asiatica extract induced apoptosis in MCF-7 cells, which was consistent with the observed nuclear condensation,

increased annexin staining, loss of mitochondrial membrane potential, and DNA breaks.

Photocytotoxicity

Centella Asiatica Meristem Cell Culture

The cytotoxicity of centella asiatica meristem cell culture (20% cells, 80% glycerin), in the presence and absence of

exposure to a non-cytotoxic dose of simulated solar light, was evaluated using the 3T3 neutral red uptake (NRU)

photocytotoxicity test.

The test material, in phosphate-buffered saline, was tested at dilutions ranging from 0.15 g/l to 30

g/l. Each dilution was applied to Balbc 3T3 fibroblasts for 1 h prior to UV exposure (5 J/cm

) for 50 minutes. Non-exposed

cultures remained in the dark. Cell viability was determined by vital dye (neutral red) uptake. The assessment parameter

obtained was the IC

(concentration of test material inhibiting 50% survival and cell growth). Centella asiatica meristem

cell culture was classified as non-phototoxic over the range of dilutions tested.

Effect on Neurotoxicity

Centella Asiatica Extract

Centella asiatica extract (aqueous extract) (100 µg/mL) mitigated amyloid-β-induced cell death in the MC65 and

SH-SY5Y neuroblastoma cell lines.

The attenuation of amyloid-β-induced alterations in tau expression and

phosphorylation in both cell lines was also noted. The authors noted that the accumulation of amyloid-β is a hallmark of

Alzheimer’s disease, and is known to result in neurotoxicity both in vivo and in vitro.

Immunomodulatory Activity

Centella Asiatica Extract

The effects of centella asiatica extract (aqueous and ethanol extracts, whole plant) on cell-mediated and humoral

immune responses was evaluated.

In human peripheral blood mononuclear cells (PBMCs), the aqueous extract of centella

asiatica (500 µg/ml) significantly increased (p <0.05) proliferation and the production of IL-2 and TNF-α. In contrast, the

ethanol extract of centella asiatica (500 µg/ml) inhibited human PBMC mitogenesis and the production of IL-2 and TNF-α

(i.e., exhibited immunosuppressive activity).

In another experiment, 3 groups of 6 male BALB/c mice were fed centella asiatica extract (aqueous extract) at doses

of 10 mg/kg, 100 mg/kg, and 300 mg/kg body weight, respectively (duration of dosing not stated), and immunized with

bovine serum albumin (BSA). The control group (6 mice) received distilled water. The experimental group dosed with 100

mg/kg body weight had significantly greater (p < 0.05) responses to both primary and secondary antibodies against BSA

when compared to the non-treated group. These statistically significant effects were not observed in the other dose groups. It

was concluded that centella asiatica extracts (aqueous and ethanol) had immunomodulating activity with respect to both non-

specific cellular and humoral immune responses.

SUMMARY

Centella asiatica, the plant source of ingredients reviewed in this safety assessment, is an herbaceous plant of the

Apiaceae family.

The following specifications for impurities relate to a material described as a hydroglycolic (propylene glycol/water)

extract of Centella asiatica (dry extract: 1.0 to 5 g/100g): heavy metals content (Pb) (< 20 ppm), arsenic (< 1 ppm), and total

aerobic germs (< 100/g).

Collectively, information supplied to FDA by industry as part of the VCRP and a survey of ingredient use

concentrations conducted by the Council indicate that the following Centella asiatica-derived ingredients are being used in

cosmetic products: centella asiatica extract, centella asiatica flower/leaf/stem extract, centella asiatica leaf extract, and

centella asiatica meristem cell culture. The highest use frequency is reported for centella asiatica extract (454 uses). The

Council survey data also indicate that Centella asiatica-derived ingredients are being used in cosmetics at maximum

ingredient use concentrations up to 0.5% (i.e., for centella asiatica extract in face and neck products).

The European Medicines Agency reports that, for cutaneous use in the treatment of leg ulcers, wounds, and burns,

etc., ointments contain 1% titrated extract of Centella asiatica (TECA). A cutaneous powder containing 2% TECA is used

for the treatment of scars, keloid scars, and burns.

Oral dosing with centella asiatica extract in human subjects yielded plasma half-lives of 2.2 h (30-mg dose) and 3.4

h (60-mg dose) for asiatic acid, with no detectable levels of the saponin remaining at 24 h post-dosing. After oral dosing of

rats with madecassoside, this saponin component of Centella asiatica was widely distributed to the heart, liver, spleen, lung

and kidney, and the levels of madecassoside in the liver and kidneys were relatively higher than in other organs. Values for

the excretion of madecassoside in bile, urine, and feces were 7.16% (0-12h), 0.25% (0-72h) and 24.68% (0-72h) of the

administered dose, respectively.

In an acute oral toxicity study of centella asiastica leaf extract involving rats, an LD

of 200 mg/kg was reported.

No systemic toxicity or complications were reported in a study in which 84 diabetic wound patients received oral doses of

centella asiatica extract (50 mg extracted asiaticoside/capsule) 3 times per day for 21 days.

The skin irritancy threshold of centella asiatica extract was determined to be > 30% in a test involving 10 guinea

pigs. In the skin sensitization phase of this study, 30% centella asiatica extract was classified as a weak sensitizer. In a

sensitization study on TECA (undiluted and at 50% in paraffin oil) involving guinea pigs, neither test material induced skin

sensitization.

Negative patch test results were reported for 20 subjects patch tested with centella asiatica extract at concentrations

of 1% and 5% in petrolatum. In HRIPT’s a cream containing 0.045% centella asiatica extract did not induce allergic contact

dermatitis in 110 subjects, and a body cream containing 0.018% centella asiatica extract did not cause clinically meaningful

irritation or allergic contact dermatitis in 52 subjects.

A cleanser containing 0.01% centella asiatica flower/leaf/stem extract (diluted to a test concentration of 0.0003%)

did not induce dermal irritation or allergic contact dermatitis in an HRIPT involving 112 subjects. An eye cream containing

0.1% centella asiatica leaf extract did not induce skin irritation or sensitization in an HRIPT involving 68 subjects. Skin

irritation also was not observed in a 48-h patch test involving the same subjects.

An eye lotion containing 0.2% centella asiatica leaf extract did not cause skin irritation or allergic contact dermatitis

in any of the 54 subjects tested in a human repeated insult patch test (HRIPT). A material with the following composition

was evaluated for skin irritation and sensitization potential in an HRIPT involving 47 subjects: centella asiatica root extract,

as % solid content in overall extract composition (0.1%), water (98.3%), potassium sorbate and phenoxyethanol preservative

blend (0.6%), and Saccharomyces lysate extract (0.1%). The results of this study were also negative.

The skin irritation and sensitization potential of centella asiatica meristem cell culture (20% in glycerol) was

evaluated in an HRIPT involving 108 subjects (mean age = 49 years). The test substance was applied at a concentration of

30% in distilled water (effective concentration = 6%) during induction, but was tested undiluted during the challenge phase.

Results were negative for skin irritation and sensitization.

In an HRIPT involving 109 subjects, a mascara containing 0.5% madecassoside did not induce primary or

cumulative skin irritation, or sensitization. All subjects were available for the evaluation of primary skin irritation potential.

However, only 104 subjects and 102 subjects were available for the evaluation of cumulative skin irritation and sensitization

potential, respectively.

In case reports, patch test results for centella asiatica extract were positive at concentrations as low as 1%. Centella

asiatica extract (10%, from leaf and stem) yielded a positive and negative reaction in separate case reports.

Results for the following ingredients were negative in the human corneal epithelial model: 0.2% centella asiatica

leaf extract, 20% centella asiatica meristem cell culture, and 1% centella asiatica root extract.

Degeneration of seminiferous tubules and a significant dose-dependent reduction in sperm density were reported in

male rats dosed orally with centella asiatica leaf extract (up to 100 mg/kg/day). Centella asiatica extract caused

antispermatogenic and antifertility effects on the reproductive system of male rats. A significant reduction (p < 0.05) in

sperm count was observed in the 200 mg/kg/day and 300 mg/kg/day dose groups, but not in the 100 mg/kg/day dose group.

Centella asiatica leaf extract was not genotoxic in a chromosomal aberration assay involving human peripheral

blood lymphocytes. Negative results were also reported for centella asiatica extract and centella asiatica meristem cell

culture in the Ames test with and without metabolic activation.

Study results indicated that asiaticoside can be classified as a weak tumor promoter in the hairless mouse epidermis,

and also seems to be very weakly carcinogenic to the dermis by surface application to the skin. Asiaticoside was applied

repeatedly to the skin of hairless mice at a concentration of 0.1% in benzene in this study.

In vitro studies on centella asiatica extract and centella asiatica leaf extract showed that these botanicals are

cytotoxic to various cancer cell lines.

The cytotoxicity of centella asiatica meristem cell culture, in the presence and absence of exposure to a non-

cytotoxic dose of simulated solar light, was evaluated using the 3T3 neutral red uptake (NRU) photocytotoxicity test. The test

material (in phosphate-buffered saline) was evaluated at dilutions ranging from 0.15 g/l to 30 g/l, and was classified as non-

phototoxic.

DISCUSSION

The Panel expressed concern about pesticide residues and heavy metals that may be present in botanical ingredients. They

stressed that the cosmetics industry should continue to use the necessary procedures to limit these impurities in the ingredient

before blending into cosmetic formulation.

Because final product formulations may contain multiple botanicals, each possibly containing similar constituents of

concern, formulators are advised to be aware of these constituents and to avoid reaching levels that may be hazardous to

consumers. For Centella asiatica-derived ingredients, the Panel was concerned about the presence of constituents that could

result in sensitization. Therefore, when formulating products, manufacturers should avoid reaching levels of plant

constituents that may cause sensitization or other adverse health effects

Centella asiatica extract (30%), extracted with diethyl ether and ethanol, was classified as a weak sensitizer in the

guinea pig maximization test. After considering these data, the Panel noted that there is little concern over sensitization

potential in humans, given the low reported maximum use concentration of 0.5% in cosmetic products. The Panel also noted

different effects of centella asiatica extract relating to the cell-mediated immune response, depending on the method of

ingredient extraction. Centella asiatica extract (aqueous extract) stimulated cytokine production, whereas centella asiatica

extract (ethanol extract) inhibited cytokine production.

Centella asiatica extract was a reproductive toxicant in male rats at daily oral doses ranging from 100 to 300

mg/kg/day, and the same was true for centella asiatica leaf extract in male rats at a daily oral dose of 100 mg/kg/day. The

Panel noted that the male reproductive toxicity induced by both extracts was observed at high doses, but that this level of

exposure, with a large margin of safety, would not be associated with daily use of cosmetic products at maximum reported

ingredient use concentrations up to 0.5% (centella asiatica extract) and 0.2% (centella asiatica leaf extract). It was agreed

that this exposure assessment could be made in the absence of dermal absorption data on Centella asiatica-derived

ingredients, having noted that copious dermal application of a product would yield a safe margin of exposure even if 100%

dermal absorption were assumed. Thus, the Panel agreed that the level of use of centella asiatica leaf extract and other

Centella asiatica-derived in cosmetics should be far below the threshold of toxicologic concern for that endpoint.

The Panel was not concerned about the carcinogenic potential of Centella asiatica-derived ingredients after

reviewing negative results for asiaticoside (a principal component of the triterpenoid fraction of Centella asitica) in a 2-year

dermal carcinogenicity study involving mice.

In addition to the available data on centella asiatica extract (whole plant extract), safety test data on centella asiatica

flower/leaf/stem extract, centella asiatica leaf extract, and centella asiatica meristem cell culture are available. Safety test

data on the following ingredients are not included in this safety assessment: centella asiatica callus culture, centella asiatica

leaf cell culture extract, centella asiatica leaf water, centella asiatica meristem cell culture extract, and centella asiatica root

extract. However, in the absence of these data, the Panel noted that centella asiatica meristem cell culture and centella

asiatica callus culture are basically the same in terms of their composition, that the root, stem, and leaves of Centella asiatica

are similar in terms of their composition, and that the greatest concentration of components (e.g., terpenoids and flavonoids)

is found in the leaf. Thus, based on similarities in composition, the available safety test data on centella asiatica extract,

centella asiatica flower/leaf/stem extract, centella asiatica leaf extract, and centella asiatica meristem cell culture are

sufficient for evaluating the safety of the ingredients for which safety test data are not available.

CONCLUSION

The CIR Expert Panel concluded that the following 9 ingredients are safe in the present practices of use and

concentration in cosmetics, as described in this safety assessment, when formulated to be non-sensitizing.

centella asiatica extract

centella asiatica callus culture*

centella asiatica flower/leaf/stem extract

centella asiatica leaf cell culture extract*

centella asiatica leaf extract

centella asiatica leaf water*

centella asiatica meristem cell culture

centella asiatica meristem cell culture extract*

centella asiatica root extract*

*Not reported to be in current use. Were ingredients in this group not in current use to be used in the future, the expectation is

that they would be used in product categories and at concentrations comparable to others in this group.

Table 1. Definitions and functions of the ingredients in this safety assessment.

Ingredient/CAS No.

Definition

Function

Centella asiatica extract

84696-21-9

84776-24-9

Centella asiatica extract, also known as gotu kola extract, is the extract of the whole

plant, Centella asiatica.

Skin-

Conditioning

Agents -

Miscellaneous

Centella asiatica callus

culture

Centella asiatica callus culture is a suspension of the cultured callus cells of Centella

asiatica.

Antioxidants; S

kin-

Conditioning

Agents -

Miscellaneous

Centella asiatica

flower/leaf/stem extract

Centella asiatica flower/leaf/stem extract is the extract of the flowers, leaves and stems

of Centella asiatica.

Skin-

Conditioning

Agents -

Miscellaneous

Centella asiatica leaf cell

culture extract

Centella asiatica leaf cell culture extract is the extract of a culture of the leaf cells of

Centella asiatica.

Antioxidants; S

kin Protectants

Centella asiatica leaf extract

Centella asiatica leaf extract is the extract of the leaves of Centella asiatica.

Skin-

Conditioning

Agents -

Miscellaneous

Centella asiatica leaf water

Centella asiatica leaf water is an aqueous solution of the steam distillate obtained from

the leaves of Centella asiatica.

Skin-

Conditioning

Agents -

Miscellaneous

Centella asiatica meristem

cell culture

Centella asiatica meristem cell culture is a suspension of the cultured meristem cells of

Centella asiatica.

Antioxidants; S

kin Protectants

Centella asiatica meristem

cell culture extract

Centella asiatica meristem cell culture extract is the extract of centella asiatica

meristem cell culture.

Skin-

Conditioning

Agents -

Emollient

Centella asiatica root extract

Centella asiatica Root Extract is the extract of the roots of Centella asiatica.

Skin-

Conditioning

Agents -

Miscellaneous

Table 2. Specifications for Centella Asiatica Extract.

Property

Value*

Appearance

Liquid

Odor

Specific

Color (Gardner Scale)

8.0 to 11.0

Specific Gravity @ 20˚C (D20/4)

1.031 to 1.061

Refractive Index @ 20˚C

1.375 to 1.405

pH (pure product)

4.5 to 6.5

Dry Extract

1.00 to 5.00 g/100g

* Values reported for a hydroglycolic (propylene glycol/water)

extract of Centella asiatica.

Table 3. Current Frequency and Concentration of Use According to Duration and Type of Exposure.

21,22

Centella Asiatica Extract

Centella Asiatica

Flower/Leaf/Stem

Extract

Centella Asiatica Leaf

Extract

# of

Uses

Conc. (%)

# of

Uses

Conc. (%)

# of

Uses

Conc. (%)

Totals/Conc. Range

454

0.00002-0.5

0.001

66 0.0017-0.2

Duration of Use

Leave-On

262

0.00002-0.5

63 0.0017-0.2

Rinse off

0.00002-0.082

0.001

3 0.02

Diluted for (bath) Use

NR NR

Exposure Type

Eye Area

0.1-0.3

0.0017-0.2

Incidental Ingestion

0.0003-0.01

Incidental Inhalation- Sprays

129*

0.0033*

38*

Incidental Inhalation- Powders

111**

0.0032-0.5**

35**

0.02-0.1**

Dermal Contact

368

0.00002-0.5

0.001

0.0017-0.2

Deodorant (underarm)

Hair - Non-Coloring

0.0005-0.003

Hair-Coloring

0.028

Nail

Mucous Membrane

0.0001-0.01

Baby Products

Centella Asiatica Meristem

Cell Culture

# of

Uses

Conc. (%)

Totals/Conc. Range

0.05-0.1

Duration of Use

Leave-On

0.05-0.1

Rinse off

Diluted for (bath) Use

Exposure Type

Eye Area

0.05

Incidental Ingestion

Incidental Inhalation- Sprays

Incidental Inhalation- Powders

3**

0.1

Dermal Contact

0.05-0.1

Deodorant (underarm)

Hair - Non-Coloring

Hair-Coloring

Nail

Mucous Membrane

Baby Products

NR = Not Reported; Totals = Rinse-off + Leave-on + Diluted for (Bath) Use Product Uses.

*It is possible that these products may be sprays, but it is not specified whether the reported uses are sprays.

**It is possible that these products may be powders, but it is not specified whether the reported uses are powders.

Note: Because each ingredient may be used in cosmetics with multiple exposure types, the sum of all exposure

type uses may not equal the sum total uses.

References

1. Nikitakis, J. and Breslawec H. P. International Cosmetic Ingredient Dictionary and Handbook. 14 ed. Washington,

DC: Personal Care Products Council, 2014.

2. United States Department of Agriculture. Germplasm Resources Information Network. Centella

asiatica. http://www.ars-grin.gov4/cgi-bin/npgs/html/tax_search.pl

. Last Updated 2015.

3. Gattefossé. Technical data sheet: Vegetol hydrocotyl GR040 Hydro (Centella Asiatica Extract). Unpublished data

submitted by the Personal Care Products Council on 3-31-2015. 2010. pp.1-3.

4. Anonymous. Method of manufacture of centella asiatica extract. Unpublished data submitted by the Personal Care

Products Council on 9-19-2014. 2014. pp.1

5. Personal Care Products Council. Information on centella asiatica extract. Method of manufacture and composition.

Unpublished data submitted by the Personal Care Products Council on 10-31-2014. 2014. pp.1

6. Babykutty, S. Padikkala J. Sathiadevan P. P. Vijayakurup V. Azis T. K. A. Srinivas P. and Gopala S. Apoptosis

induction of Centella asiatica on human breast cancer cells. Afr.J.Trad.CAM. 2009;6(1):9-16.

7. Berrocal, R. Vasudevaraju P. Indi S. S. Rao K. R. S. S. an Rao K. S. In vitro evidence that an aqueous extract of

Centella asiatica modulates a-synuclein aggregation dynamics. Journal of Alzheimer's Disease.

2014;39:457-465.

8. Heidari, M., Heidari-Vala, H., Sadeghi, M. R., and Akhondi, M. M. The inductive effects of Centella asiatica on rat

spermatogenic cell apoptosis in vivo. J Nat Med. 2012;66(2):271-278.

9. Personal Care Products Council. Centella asiatica meristem cell culture. Method of manufacture, composition, and

impuirities. Unpublished data submitted by the Personal Care Products Council on 1-30-2015. 2015. pp.1

10. Gohil, K. J. Patel J. A. and Gajjar A. K. Pharmacological review on Centella asiatica: A potential herbal cure-all.

Indian J.Pharm.Sci. 2010;72(5):546-556.

11. Anonymous. Monograph. Centella asiatica. Alternative Medicine Review. 2007;12(1):69-72.

12. Siddiqui, B. S. Aslam H. Ali S. T. Khan S. and Begum S. Chemical constituents of Centella asiatica. Journal of

Asian Natural Products Research. 2007;9(4):407-414.

13. James, J. T. and Dubery I. A. Pentacyclic triterpenoids from the medicinal herb, Centella asiatica (L.) Urban.

Molecules. 2009;14:3922-3941.

14. Gallego, A. Ramirez-Estrada K. Vidal-Limon H. R. Hidalgo D. Lalaleo L. Kayani W. K. Cusido R. M. and Palazon

J. Biotechnological production of centellosides in cell cultures of Centella asiatica (L) Urban. Eng.Life Sci.

2014;14:633-642.

15. Bylka, W. Znajdek-Awizen P. Studzinska-Sroka E. and Brezezinska M. Review article. Centella asiatica in

cosmetology. Postep.Derm.Alergol. 2013;1:46-49.

16. Zainol, N. A. and Voo, S. C. Sarmidi M. R. and Aziz R. A. Profiling of Centella Asiatica (L.) Urban Extract. The

Malaysian Journal of Analytical Sciences. 2008;12(2):322-327.

17. Biradar, S. R. and Rachetti B. D. Extraction of some secondary metabolites and thin layer chromatography from

different parts of Centella asiatica L. (URB). American Journal of Life Sciences. 2013;1(6):243-247.

18. Chong, N. and Aziz Z. A systematic review on the chemical constituents of Centella asiatica. Research Journal of

Pharmaceutical, Biological and Chemical Sciences. 2011;2(3):445-459.

19. Ong, G. H. Yap C. K. Mahmood M. Tan S. G. and Hamzah S. Barium levels in soils in Centella asiatica. Tropical

Life Sciences Research. 2013;24(1):55-70.

20. Dal, Toso R. Plant Cell Culture: The Best of Nature Amplified. Presentation at the Cosmetic Ingredient Review

Expert Panel Meeting on June 15, 2015. Submitted by Roberto Dal Toso, Ph.D., Manager of the Instituto

di Richerch Biotechnologiche (I.R.B.), SpA, in Altavilla Vicentina, Italy. 2015. pp.1-11.

21. Food and Drug Administration (FDA). Information supplied to FDA by industry as part of the VCRP FDA database.

2015. Washington, D.C.: FDA.

22. Personal Care Products Council. Concentration of use by FDA product category: Centella asiatica-derived

ingredients. Unpublished data submitted by the Personal Care Products Council on 2-23-2015. 2015. pp.1

23. Rothe, H. Special aspects of powders in decorative cosmetics. Unpublished information presented at the 26

September 2011 CIR Expert Panel Meeting. Washington, D.C. 2011.

24. Food and Drug Administration (FDA). Drugs@FDA. FDA-approved drug products. http://www.fda.gov

. Last

Updated 2014. Date Accessed 11-6-2014.

25. Gonzalo Garijo, M. A., Revenga, Arranz F., and Bobadilla, Gonz lez P. Allergic contact dermatitis due to Centella

asiatica: a new case. Allergol Immunopathol.(Madr.). 1996;24(3):132-134.

26. Izu, R., Aguirre, A., Gil, N., and Diaz Perez, J. L. Allergic contact dermatitis from a cream containing Centella

asiatica extract. Contact Dermatitis. 1992;26(3):192-193.

27. European Medicines Agency. Assessment report on Centella asiatica (L.) Urban,

herba.

http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-

_HMPC_assessment_report/2012/06/WC500128144.pdf. Last Updated 2012.

28. Leng, D. Han W. Rui Y. Dai Y. and Xia Y. In vivo disoposition and metabolism of madecassoside, a major bioactive

constitent in Cetella asiatica (L.) Urb. Journal of Ethnopharmacology. 2013;150:601-608.

29. Grimaldi, R., De, Ponti F., D'Angelo, L., Caravaggi, M., and Crema, A. Pharmacokinetics of the total triterpenic

fraction of Centella asiatica after single and multiple administrations to healthy volunteers: new assay for

asiatic acid. J.Ethnopharmacol. 1990;28(2):235-241.

30. Paocharoen, V. The efficacy and side effects of oral Centella asiatica extract for wound healing promotion in

diabetic wound patients. J.Med.Assoc. 2010;93(7):S166-S170.

31. Yunianto, I., Das, S., and Mat, Noor M. Antispermatogenic and antifertility effect of Pegaga (Centella asiatica L) on

the testis of male Sprague-Dawley rats. Clin Ter. 2010;161(3):235-239.

32. Siddique, Y. H., Ara, G., Beg, T., Faisal, M., Ahmad, M., and Afzal, M. Antigenotoxic role of Centella asiatica L.

extract against cyproterone acetate induced genotoxic damage in cultured human lymphocytes. Toxicol In

Vitro. 2008;22(1):10-17.

33. Yen, G. C., Chen, H. Y., and Peng, H. H. Evaluation of the cytotoxicity, mutagenicity and antimutagenicity of

emerging edible plants. Food Chem Toxicol. 2001;39(11):1045-1053.

34. Eurofins Biolab. Bacterial reverse mutation assay on centella asiatica meristem cell culture. Unpublished data

submitted by the Personal Care Products Council on 1-30-2015. 2010. pp.1-14.

35. Laerum, O. D. and Iversen O. H. Reticuloses and epidermal tumors in hairless mice after topical skin applications of

cantharidin and asiaticoside. Cancer Research. 1972;32:1463-1469.

36. Hausen, B. M. Centella asiatica (Indian pennywort), an effective therapeutic but a weak sensitizer. Contact

Dermatitis. 1993;29:175-179.

37. Anonymous. Summary of a guinea pig sensitization study (OECD 406) of TECA (titrated extract of Centella

asiatica). Unpublished data submitted by the Personal Care Products Council on 12-11-2014. 2014. pp.1

38. Gomes, J., Pereira, T., Vilarinho, C., Duarte, Mda L., and Brito, C. Contact dermatitis due to Centella asiatica.

Contact Dermatitis. 2010;62(1):54-55.

39. Thomas J.Stephens & Associates, Inc. Human repeat insult patch test (cream containing 0.045% centella asiatica

extract). Unpublished data submitted by the Personal Care Products Council on 4-7-2015. 1999. pp.1-11.

40. RCTS, Inc. Human repeat insult patch test (body cream containing 0.018% centella asiatica extract). Unpublished

data submitted by the Personal Care Products Council on 4-7-2015. 2009. pp.1-10.

41. Consumer Product Testing Company. Summary of a repeated insult patch test of a cleanser containing 0.01%

centella asiatica flower/leaf/stem extract. Unpublished data submitted by the Personal Care Products

Council on 4-3-2015. 2011. pp.1-3.

42. Essex Testing Clinic, Inc. Clinical safety evaluation. Repeated insult patch test of an eye lotion containing 0.2%

centella asiatica leaf extract. 2012. pp.1-10.

43. Allergisa. Summary of a repeated insult patch test of an eye cream containing 0.1% centella asiatica leaf extract.

Unpublished data submitted by the Personal Care Products Council on 4-3-2015. 2011. pp.1-4.

44. Consumer Product Testing Co. Repeated insult patch test. Centella asiatica root extract. Unpublished data submitted

by the Personal Care Products Council on 2-6-2015. 2002. pp.1-9.

45. I.E.C.Bulgarie. Summary of sensitization and cutaneous compatibility study of a mascara containing 0.5%

madecassoside. Unpublished data submitted by the Personal Care Products Council on 4-12-2015. 2009.

pp.1-6.

46. Eun, H. C. and Lee, A. Y. Contact dermatitis due to madecassol. Contact Dermatitis. 1985;13(5):310-313.

47. Personal Care Products Council. Comments on the Scientific Literature Review on Centella asiatica-derived

ingredients. Unpublished data submitted by the Personal Care Products Council on 11-4-2014. 2014. pp.1

48. Danese, P. Carnevali C. and Bertazzoni M. G. Allergic contact dermatitis due to Centella asiatica extract. Contact

Dermatitis. 1994;31:201

49. Bilbao, I., Aguirre, A., Zabala, R., Gonzalez, R., Raton, J., and Diaz Perez, J. L. Allergic contact dermatitis from

butoxyethyl nicotinic acid and Centella asiatica extract. Contact Dermatitis. 1995;33(6):435-436.

50. Jorge, O. A. and Jorge, A. D. Hepatotoxicity associated with the ingestion of Centella asiatica. Rev Esp.Enferm.Dig.

2005;97(2):115-124.

51. Institute for In Vitro Sciences, Inc. Topical application ocular irritation screening assay using the EpiocularTM

human cell construct of an eye lotion containing 0.2% centella asiatica leaf extract. Unpublished data

submitted by the Personal Care Products Council on 2-4-2015. 2012. pp.1-13.

52. Eurofins Biolab. In vitro eye irritation test on "centella asiatica meristem cell culture": Human corneal epithelial

model (HCE). Unpublished data submitted by the Personal Care Products Council on 1-30-2015. 2010.

pp.1-9.

53. Consumer Product Testing Co. The MatTek Corporation EpiOcular

tissue model in vitro toxicity testing system.

Centella asiatica root extract. Unpublished data submitted by the Personal Care Products Council on 2-6-

2015. 2003. pp.1-5.

54. Bian, D. Zhang J. Wu X. Dou Y. Yang Y. Tan Q. Xia Y. ande Gong Z. Asiatic acid isolated from Centella asiatica

inhibits TGFb1-induced collagen expression in human keloid fibroblasts via PPAR-g activation.

Int.J.Biol.Sci. 2013;9:1032-1042.

55. Hashim, P. The effect of Centella asiatica, vitamins, glycolic acid and their mixtures preparations in stimulating

collagen and fibronectin synthesis in cultured human skin fibroblast. Pak.J.Pharm.Sci. 2014;27(2):233-

237.

56. Suguna, L. K. Sivakumar P. and Chandrakasan G. Effects of Centella asiatica extract on dermal wound healing in

rats. Indian J.Exp.Biol. 1996;34:1208-1211.

57. Shetty, B. S. Udupa S. L. Udupa A. L. and Somayaji S. N. Effect of Centella asiatica L (Umbelliferae) on normal

and dexamethasone-suppressed wound healing in Wistar albino rats. Int.J.Low Extrem.Wounds.

2006;5:137-143.

58. Arpaia, M. R. Ferrone R. Amitrano M. et al. Effects of Centella asiatica extract on mucopolysaccharide metabolism

in subjects with varicose veins. Int.J.Clin.Pharmacol.Res. 1990;10:229-233.

59. Soumyanath, A. Zhong Y. P. Gold S. A. et al. Centella asiatica accelerates nerve regeneration upon oral

administration and contains multiple active fractions increasing neurite elongation in vitro.

J.Pharm.Pharmacol. 2005;57:1221-1229.

60. Pittella, F., Dutra, R. C., Junior, D. D., Lopes, M. T., and Barbosa, N. R. Antioxidant and cytotoxic activities of

Centella asiatica (L) Urb. Int J Mol Sci. 2009;10(9):3713-3721.

61. Evic France. Assessment of the phototoxic potential of a test element (centella asiatica meristem cell culture). 3T3

RNU photo-cytotoxicity test. Unpublished data submitted by the Personal Care Products Council on 1-30-

2015. 2010. pp.1-19.

62. Gray, N. E., Morr‚, J., Kelley, J., Maier, C. S., Stevens, J. F., Quinn, J. F., and Soumyanath, A. Caffeoylquinic Acids

in Centella asiatica Protect against Amyloid-β Toxicity. J Alzheimers Dis. 2014;40(2):359-373.

63. Punturee, K. Wild C. P. Kasinrerk W. and Vinitketkumnuen U. Immunomodulatory activities of Centella asiatica

and Rhinacanthus nasutus extracts. Asian Pacific Journal of Cancer Prevention. 2005;6:396-400.